Evaluation of reference tissue models for the analysis of [ 11C](R)-PK11195 studies

Journal of Cerebral Blood Flow and Metabolism

Volumn 26, Issue 11, 2006, Pages 1431-1441

  Kropholler, Marc A ^a   Boellaard, Ronald ^a   Schuitemaker, Alie ^a   Folkersma, Hedy ^a   Van Berckel, Bart N M ^a   Lammertsma, Adriaan A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Microglia; Peripheral benzodiazepine receptor; PET (positron emission tomography); PK11195; Reference tissue models; Tracer kinetic modelling

Indexed keywords

BENZODIAZEPINE RECEPTOR; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; BLOOD VOLUME; BRAIN INJURY; FEMALE; HISTOCOMPATIBILITY; HUMAN; HUMAN TISSUE; KINETICS; MALE; MONTE CARLO METHOD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN HEMORRHAGE, TRAUMATIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOQUINOLINES; KINETICS; MALE; MICROGLIA; MIDDLE AGED; MODELS, STATISTICAL; MONTE CARLO METHOD; RECEPTORS, GABA-A; REFERENCE STANDARDS;

EID: 33750365126     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600289     Document Type: Article

References (41)

1. Adam LE, Jears J, Ostertag H, Trojan H, Bellemann ME, Brix G (1997) Performance of the Whole-Body PET scanner ECAT EXACT HR+ following the IEC standard. IEEE Trans Nucl Sci 44:1172-9
2. Banati RB, Cagnin A, Brooks DJ, Gunn RN, Myers R, Jones T, Birch R, Anand P (2001) Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport 12:3439-42
3. 11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 53:2199-203
4. 3H]PK11195 binding to activated microglia. J Neurocytol 26:77-82
5. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123(Part 11):2321-37
6. Boellaard R, van Lingen A, van Balen SC, Hoving BG, Lammertsma AA (2001) Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET. Eur J Nucl Med 28:81-9
7. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ (1997) Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 38:1614-23
8. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB (2001a) In-vivo measurement of activated microglia in dementia. Lancet 358:461-7
9. 11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124:2014-27
10. Cagnin A, Rossor M, Sampson EL, Mackinnon T, Banati RB (2004) In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol 56:894-7
11. Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O (2002) Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci 15:991-8
12. Debruyne JC, Van Laere KJ, Versijpt J, De Vos F, Eng JK, Strijckmans K, Santens P, Achten E, Slegers G, Korf J, Dierckx RA, De Reuck JL (2002) Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients. Acta Neurol Belg 102:127-35
13. 11C]PK11195. Eur J Neurol 10:257-64
14. 11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61:686-9
15. Gerhard A, Neumaier B, Elitok E, Glatting G, Ries V, Tomczak R, Ludolph AC, Reske SN (2000) In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport 11:2957-60
16. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB (2005a) Evolution of microglial activation in patients after ischemic stroke: a [(11)C](R)-PK11195 PET study. Neuroimage 24:591-5
17. Gerhard A, Trender-Gerhard I, Turkheimer F, Quinn NP, Bhatia KP, Brooks DJ (2005b) In vivo imaging of microglial activation with [(11)C](R)-PK11195 PET in progressive supranuclear palsy. Mov Disord 21:89-93
18. Gerhard A, Watts J, Trender-Gerhard I, Turkheimer F, Banati RB, Bhatia K, Brooks DJ (2004) In vivo imaging of microglial activation with [(11)C](R)-PK11195 PET in corticobasal degeneration. Mov Disord 19:1221-6
19. Goerres GW, Revesz T, Duncan J, Banati RB (2001) Imaging cerebral vasculitis in refractory epilepsy using [(11)C](R)-PK11195 positron emission tomography. AJR Am J Roentgenol 176:1016-8
20. 11C]PK11195 metabolite fractions in plasma. Eur J Nucl Med 30:S242
21. Groom GN, Junck L, Foster NL, Frey KA, Kuhl DE (1995) PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. J Nucl Med 36:2207-10
22. Gunn RN, Gunn SR, Cunningham VJ (2001) Positron emission tomography compartmental models. J Cereb Blood Flow Metab 21:635-52
23. Henkel K, Karitzky J, Schmid M, Mader I, Glatting G, Unger JW, Neumaier B, Ludolph AC, Reske SN, Landwehrmeyer GB (2004) Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration. Mov Disord 19:817-21
24. Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA (1992) Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12:47-54
25. Kropholler MA, Boellaard R, Schuitemaker A, van Berckel BN, Luurtsema G, Windhorst AD, Lammertsma AA (2005) Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies. J Cereb Blood Flow Metab 25:842-51
26. Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, Frackowiak RS (1996a) Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 16:42-52
27. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-8
28. Lammertsma AA, Turjanski N, Hume SP, Luthra SK, Osman S, Piccini P, Brown DJ, Carroll FI, Brooks DJ (1996b) Quantification of dopamine transporter studies using carbon-11 labelled RTI-121 and PET. J Nucl Med 37:109P
29. Logan J (2000) Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 27:661-70
30. Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P (1997) Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 16:187-98
31. Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka T (2005) Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol 57:168-75
32. Pappata S, Cornu P, Samson Y, Prenant C, Benavides J, Scatton B, Crouzel C, Hauw JJ, Syrota A (1991) PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J Nucl Med 32:1608-10
33. Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, Jones T, Kreutzberg GW, Banati RB (2000) Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology 55:1052-4
34. Ramsay SC, Weiller C, Myers R, Cremer JE, Luthra SK, Lammertsma AA, Frackowiak RS (1992) Monitoring by PET of macrophage accumulation in brain after ischaemic stroke. Lancet 339:1054-5
35. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143-55
36. 11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15:601-9
37. Turner MR, Gerhard A, Al Chalabi A, Shaw CE, Hughes RA, Banati RB, Brooks DJ, Leigh PN (2005) Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET. J Neurol Neurosurg Psychiatry 76:871-4
38. Venneti S, Lopresti BJ, Wang G, Bissel SJ, Mathis CA, Meltzer CC, Boada F, Capuano III S, Kress GJ, Davis DK, Ruszkiewicz J, Reynolds IJ, Murphey-Corb M, Trichel AM, Wisniewski SR, Wiley CA (2004) PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS. J Clin Invest 113:981-9
39. Versijpt J, Debruyne JC, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, Achten E, Slegers G, Dierckx RA, Korf J, De Reuck JL (2005) Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult Scler 11:127-34
40. Versijpt JJ, Dumont F, Van Laere KJ, Decoo D, Santens P, Audenaert K, Achten E, Slegers G, Dierckx RA, Korf J (2003) Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Eur Neurol 50:39-47
41. West J, Fitzpatrick JM, Wang MY, Dawant BM, Maurer Jr CR, Kessler RM, Maciunas RJ, Barillot C, Lemoine D, Collignon A, Maes F, Suetens P, Vandermeulen D, van den Elsen PA, Napel S, Sumanaweera TS, Harkness B, Hemler PF, Hill DL, Hawkes DJ, Studholme C, Maintz JB, Viergever MA, Malandain G, Woods RP (1997) Comparison and evaluation of retrospective intermodality brain image registration techniques. J Comput Assist Tomogr 21:554-66